Folic acid supplementation improves vascular function in professional dancers with endothelial dysfunction

PM and R

Volumn 3, Issue 11, 2011, Pages 1005-1012

  Hoch, Anne Z ^a   Papanek, Paula ^b   Szabo, Aniko ^a   Widlansky, Michael E ^a   Gutterman, David D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MARQUETTE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; TRACE ELEMENT;

ADULT; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DANCING; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HUMAN EXPERIMENT; INTERVIEW; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; UNITED STATES;

ADOLESCENT; ADULT; BRACHIAL ARTERY; CROSS-SECTIONAL STUDIES; DANCING; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; FEMALE; FOLIC ACID; HUMANS; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; VASCULAR DISEASES; VASODILATION; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 82955212917     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2011.02.014     Document Type: Article

References (51)

1. Hoch A.Z., Dempsey R.L., Carrera G.F., et al. Is there an association between athletic amenorrhea and endothelial cell dysfunction?. Med Sci Sports Exerc 2003, 35:377-383.
2. Rickenlund A., Eriksson M.J., Schenck-Gustafsson K., Hirschberg A.L. Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile. J Clin Endocrinol Metab 2005, 90:1354-1359.
3. Warren M.P., Brooks-Gunn J., Hamilton L.H., Warren L.F., Hamilton W.G. Scoliosis and fractures in young ballet dancers. Relation to delayed menarche and secondary amenorrhea. N Engl J Med 1986, 314:1348-1353.
4. Warren M.P., Brooks-Gunn J., Fox R.P., Holderness C.C., Hyle E.P., Hamilton W.G. Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: A longitudinal study. J Clin Endocrinol Metab 2002, 87:3162-3168.
5. Brooks-Gunn J., Warren M.P., Hamilton L.H. The relation of eating problems and amenorrhea in ballet dancers. Med Sci Sports Exerc 1987, 19:41-44.
6. Frusztajer N.T., Dhuper S., Warren M.P., Brooks-Gunn J., Fox R.P. Nutrition and the incidence of stress fractures in ballet dancers. Am J Clin Nutr 1990, 51:779-783.
7. Warren M.P., Voussoughian F., Geer E.B., Hyle E.P., Adberg C.L., Ramos R.H. Functional hypothalamic amenorrhea: Hypoleptinemia and disordered eating. J Clin Endocrinol Metab 1999, 84:873-877.
8. Holderness C.C., Brooks-Gunn J., Warren M.P. Eating disorders and substance use: A dancing vs a nondancing population. Med Sci Sports Exerc 1994, 26:297-302.
9. Hoch A.Z., Papanek P., Szabo A., Widlansky M.E., Schimke J.E., Gutterman D.D. Association between the female triad athlete and endothelial dysfunction in dancers. Clin J Sports Med 2011, 21:119-125.
10. Mendelsohn M.E. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002, 89:12E-17E.
11. Chambliss K.L., Shaul P.W. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 2002, 23:665-686.
12. Balligand J.L., Feron O., Dessy C. eNOS activation by physical forces: From short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol Rev 2009, 89:481-534.
13. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235-1241.
14. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101:1899-1906.
15. Woo K.S., Chook P., Lolin Y.I., Sanderson J.E., Metreweli C., Celermajer D.S. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 1999, 34:2002-2006.
16. Rickenlund A., Eriksson M.J., Schenck-Gustafsson K., Hirschberg A.L. Oral contraceptives improve endothelial function in amenorrheic athletes. J Clin Endocrinol Metab 2005, 90:3162-3167.
17. Heiss G., Wallace R., Anderson G.L., et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008, 299:1036-1045.
18. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
19. Chlebowski R.T., Anderson G.L., Gass M., et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010, 304:1684-1692.
20. Chambers J.C., Ueland P.M., Obeid O.A., Wrigley J., Refsum H., Kooner J.S. Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000, 102:2479-2483.
21. Mangoni A.A., Arya R., Ford E., et al. Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial. Thromb Res 2003, 110:13-17.
22. Deol P.S., Barnes T.A., Dampier K., John P.K., Oppenheimer C., Pavord S.R. The effects of folic acid supplements on coagulation status in pregnancy. Br J Haematol 2004, 127:204-208.
23. Mangoni A.A., Ouldred E., Swif C.G., et al. Vascular and blood pressure effects of folic acid in older patients with cardiovascular disease. J Am Geriatr Soc 2001, 49:1003-1004.
24. Mangoni A.A., Sherwood R.A., Swift C.G., Jackson S.H. Folic acid enhances endothelial function and reduces blood pressure in smokers: A randomized controlled trial. J Intern Med 2002, 252:497-503.
25. Mangoni A.A., Sherwood R.A., Asonganyi B., Swift C.G., Thomas S., Jackson S.H. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens 2005, 18(2, pt 1):220-226.
26. Schutte A.E., Huisman H.W., Oosthuizen W., van Rooyen J.M., Jerling J.C. Cardiovascular effects of oral supplementation of vitamin C, E and folic acid in young healthy males. Int J Vitam Nutr Res 2004, 74:285-293.
27. Undas A., Domagala T.B., Jankowski M., Szczeklik A. Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. Thromb Res 1999, 95:281-288.
28. van Dijk R.A., Rauwerda J.A., Steyn M., Twisk J.W., Stehouwer C.D. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: A 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 2001, 21:2072-2079.
29. Verhaar M.C., Wever R.M., Kastelein J.J., van Dam T., Koomans H.A., Rabelink T.J. 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 1998, 97:237-241.
30. Verhaar M.C., Wever R.M., Kastelein J.J., et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia: A randomized placebo-controlled trial. Circulation 1999, 100:335-338.
31. van Etten R.W., de Koning E.J., Verhaar M.C., Gaillard C.A., Rabelink T.J. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 2002, 45:1004-1010.
32. Doshi S.N., McDowell I.F., Moat S.J., et al. Folate improves endothelial function in coronary artery disease: An effect mediated by reduction of intracellular superoxide?. Arterioscler Thromb Vasc Biol 2001, 21:1196-1202.
33. Doshi S.N., McDowell I.F., Moat S.J., et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002, 105:22-26.
34. Wever R.M., van Dam T., van Rijn H.J., de Groot F., Rabelink T.J. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 1997, 237:340-344.
35. Hoch A.Z., Lynch S.L., Jurva J.W., Schimke J.E., Gutterman D.D. Folic acid supplementation improves vascular function in amenorrheic runners. Clin J Sport Med 2010, 20:205-210.
36. Hoch A.Z., Pajewski N.M., Hoffmann R.G., Schimke J.E., Gutterman D.D. Possible relationship of folic acid supplementation and improved flow-mediated dilation in premenopausal, eumenorrheic athletic women. J Sports Sci Med 2009, 8:123-129.
37. Hashimoto M., Akishita M., Eto M., et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995, 92:3431-3435.
38. Mather K.J., Norman E.G., Prior J.C., Elliott T.G. Preserved forearm endothelial responses with acute exposure to progesterone: A randomized cross-over trial of 17-beta estradiol, progesterone, and 17-beta estradiol with progesterone in healthy menopausal women. J Clin Endocrinol Metab 2000, 85:4644-4649.
39. Williams M.R., Westerman R.A., Kingwell B.A., et al. Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab 2001, 86:5389-5395.
40. R: A language and environment for statistical computing 2006, R Development Core Team, R Foundation for Statistical Computing, Vienna, Austria, Accessed November 15, 2010. http://www.R-project.org.
41. Brevetti G., Silvestro A., Schiano V., Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003, 108:2093-2098.
42. Hijmering M.L., Stroes E.S., Pasterkamp G., Sierevogel M., Banga J.D., Rabelink T.J. Variability of flow mediated dilation: Consequences for clinical application. Atherosclerosis 2001, 157:369-373.
43. Teragawa H., Kato M., Kurokawa J., Yamagata T., Matsuura H., Chayama K. Endothelial dysfunction is an independent factor responsible for vasospastic angina. Clin Sci (Lond) 2001, 101:707-713.
44. Moens A.L., Claeys M.J., Wuyts F.L., et al. Effect of folic acid on endothelial function following acute myocardial infarction. Am J Cardiol 2007, 99:476-481.
45. Title L.M., Ur E., Giddens K., McQueen M.J., Nassar B.A. Folic acid improves endothelial dysfunction in type 2 diabetes-an effect independent of homocysteine-lowering. Vasc Med 2006, 11:101-109.
46. Hathcock J.N. Vitamins and minerals: efficacy and safety. Am J Clin Nutr 1997, 66:427-437.
47. The FDA Safety Information and Adverse Event Reporting Program: Medical product safety information U.S. Food and Drug Administration, Accessed November 20, 2010. http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm.
48. Birnbacher R., Messerschmidt A.M., Pollak A.P. Diagnosis and prevention of neural tube defects. Curr Opin Urol 2002, 12:461-464.
49. Herbert V. Folic acid. Modern Nutrition in Health and Disease 1999, 433-466. Williams & Wilkins, Baltimore, MD. M. Shils, J. Olson, M. Shike, A. Ross (Eds.).
50. Dietary supplement fact sheet: Folate National Institutes of Health, Office of Dietary Supplements, Accessed November 19, 2010. http://ods.od.nih.gov/factsheets/folate.
51. Cole B.F., Baron J.A., Sandler R.S., et al. Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. JAMA 2007, 297:2351-2359.